Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Cryo Cell International (CCEL) Assets Average (2016 - 2025)

Cryo Cell International (CCEL) has disclosed Assets Average for 15 consecutive years, with $62.4 million as the latest value for Q4 2025.

  • On a quarterly basis, Assets Average fell 2.13% to $62.4 million in Q4 2025 year-over-year; TTM through Nov 2025 was $62.4 million, a 2.13% decrease, with the full-year FY2025 number at $63.2 million, down 2.28% from a year prior.
  • Assets Average was $62.4 million for Q4 2025 at Cryo Cell International, down from $63.8 million in the prior quarter.
  • In the past five years, Assets Average ranged from a high of $75.7 million in Q1 2021 to a low of $29.8 million in Q3 2021.
  • A 5-year average of $61.7 million and a median of $63.5 million in 2024 define the central range for Assets Average.
  • Peak YoY movement for Assets Average: tumbled 33.16% in 2021, then skyrocketed 104.71% in 2022.
  • Cryo Cell International's Assets Average stood at $60.0 million in 2021, then rose by 9.63% to $65.8 million in 2022, then rose by 2.14% to $67.2 million in 2023, then decreased by 5.1% to $63.8 million in 2024, then decreased by 2.13% to $62.4 million in 2025.
  • Per Business Quant, the three most recent readings for CCEL's Assets Average are $62.4 million (Q4 2025), $63.8 million (Q3 2025), and $64.4 million (Q2 2025).